Wed, 20th Nov 2013 07:11
LONDON, Nov 20 (Reuters) - GlaxoSmithKline said onWednesday it had completed the sale of 28.2 million shares inAspen Pharmacare at 250 rand each, raising grossproceeds of 7.059 billion rand ($694 million).
Shares in the South African drugmaker closed at 267.40 randon Tuesday.
GSK had previously said it planned to reduce its investmentin the South African drugmaker by one third, while remainingcommitted to working closely with Aspen. It now has a reducedstake of 12.4 percent.
CHICAGO/LONDON, May 27 (Reuters) - The United States and Europe are taking steps to acquire or manufacture H5N1 bird flu vaccines that could be used...
(Sharecast News) - London stocks closed with mixed results on Friday, influenced by earlier declines in the US and Asian markets, as investors reacted...
(Alliance News) - Stock prices in London opened lower on Friday, with sentiment hurt across the globe.
(Alliance News) - GSK PLC on Friday welcomed the jury verdict in the Valadez case in Illinois state court, which found in GSK's favour in the first Za...
(Alliance News) - Stocks are called to open lower on Friday, following New York lower, as hopes of interest rate cuts have come into question.
Glaxosmithkline (GSK)